BR112014023670A8 - Composto, composição farmacêutica e suo de um composto - Google Patents

Composto, composição farmacêutica e suo de um composto

Info

Publication number
BR112014023670A8
BR112014023670A8 BR112014023670A BR112014023670A BR112014023670A8 BR 112014023670 A8 BR112014023670 A8 BR 112014023670A8 BR 112014023670 A BR112014023670 A BR 112014023670A BR 112014023670 A BR112014023670 A BR 112014023670A BR 112014023670 A8 BR112014023670 A8 BR 112014023670A8
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
switch
prodrugs
treat
Prior art date
Application number
BR112014023670A
Other languages
English (en)
Other versions
BR112014023670A2 (pt
Inventor
Pietro Imbimbo Bruno
Raveglia Luca
Original Assignee
Chiesi Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farm Spa filed Critical Chiesi Farm Spa
Publication of BR112014023670A2 publication Critical patent/BR112014023670A2/pt
Publication of BR112014023670A8 publication Critical patent/BR112014023670A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/753—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/36—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/40—Unsaturated compounds containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Abstract

COMPOSTO, COMPOSIÇÃO FARMACÊUTICA E SUO DE UM COMPOSTO A presente invenção refere-se a pró-fármacos de ácidos 1-(2-halobifenil-4-il) alcanocarboxílicos, a composições farmacêuticas desses pró-fármacos, a um processo para o seu preparo e ao seu uso para prevenir e/ou tratar doenças neurodegenerativas, melhorar a função cognitiva e para tratar o comprometimento cognitivo.
BR112014023670A 2012-04-04 2013-04-03 Composto, composição farmacêutica e suo de um composto BR112014023670A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12163074 2012-04-04
PCT/EP2013/057025 WO2013150072A1 (en) 2012-04-04 2013-04-03 Derivatives of 1-(2-halo-biphenyl-4-yl)- alkanecarboxylic acids for the treatment of neurodegenerative diseases

Publications (2)

Publication Number Publication Date
BR112014023670A2 BR112014023670A2 (pt) 2017-06-20
BR112014023670A8 true BR112014023670A8 (pt) 2017-07-25

Family

ID=48227176

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014023670A BR112014023670A8 (pt) 2012-04-04 2013-04-03 Composto, composição farmacêutica e suo de um composto

Country Status (10)

Country Link
US (1) US8835494B2 (pt)
EP (1) EP2834214A1 (pt)
KR (1) KR20140144178A (pt)
CN (1) CN104169251A (pt)
AR (1) AR090581A1 (pt)
BR (1) BR112014023670A8 (pt)
CA (1) CA2869418A1 (pt)
HK (1) HK1200439A1 (pt)
RU (1) RU2014139971A (pt)
WO (1) WO2013150072A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150335596A1 (en) * 2014-05-26 2015-11-26 Chiesi Farmaceutici S.P.A. 1-(2-fluorobiphenyl-4-yl)-cyclopropanecarboxylic acid derivatives for the treatment of down's syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101088272B1 (ko) 2003-02-21 2011-11-30 키에시 파르마슈티시 엣스. 피. 에이. 신경 퇴행성 질환의 치료를 위한 1-페닐알캔카복실산추출물
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
WO2006016219A2 (en) 2004-08-03 2006-02-16 Chiesi Farmaceutici S.P.A. Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
EP2133322A1 (en) 2008-06-11 2009-12-16 CHIESI FARMACEUTICI S.p.A. Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
PT2462098E (pt) 2009-08-04 2013-12-04 Chiesi Farma Spa Processos para a preparação de derivados de ácido 1-(2- halobifenil-4-il)-ciclopropanocarboxílico

Also Published As

Publication number Publication date
HK1200439A1 (en) 2015-08-07
WO2013150072A1 (en) 2013-10-10
BR112014023670A2 (pt) 2017-06-20
RU2014139971A (ru) 2016-04-20
CN104169251A (zh) 2014-11-26
US8835494B2 (en) 2014-09-16
US20130267592A1 (en) 2013-10-10
EP2834214A1 (en) 2015-02-11
KR20140144178A (ko) 2014-12-18
CA2869418A1 (en) 2013-10-10
AR090581A1 (es) 2014-11-19

Similar Documents

Publication Publication Date Title
BR112017022604A2 (pt) composto, composição farmacêutica, uso de um composto e de uma combinação, e, combinação
BR112018005497A2 (pt) compostos heterocíclicos e usos dos mesmos
PH12015501385A1 (en) Autotaxin inhibitors
BR112012027509A2 (pt) composto, processo para a preparação de composto, composição farmacêutica, uso de composto, e, método
TR201902788T4 (tr) Nörodejeneratif hastalıkların tedavisinde kullanışlı 1-arilkarbonil-4-oksi-piperidin bileşikleri.
BR112015001101A2 (pt) formas cristalinas de um inibidor de prolil hidroxilase
PH12016500094A1 (en) Autotaxin inhibitors
BR112014010183B8 (pt) Composto, composição farmacêutica, produto, e, uso de um composto
BR112015031073A2 (pt) inibidores bicíclicos de bromodomínio
WO2014062733A3 (en) Substituted benzene compounds
BR112015011456A2 (pt) compostos de aminopirimidina como inibidores de egfr mutantes contendo t790m
BR112014021531A8 (pt) composto, composição farmacêutica e usos dos mesmos
BR112016014020A8 (pt) moduladores de tetra-hidropiridopirazinas de gpr6.
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
UY33627A (es) Compuestos para tratar enfermedades neurodegenerativas
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MX2016005446A (es) Intervenciones a base de angiopoyetina para tratar la malaria cerebral.
BR112012032248A2 (pt) composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
BR112017010311A2 (pt) 4-oxo-3,4-dihidro-1,2,3-benzotriazinas como moduladores de gpr139
WO2012104823A3 (en) Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
EA201690783A1 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
IN2014MN02056A (pt)
BR112014030720A8 (pt) composto, composição farmacêutica e usos de inibidores de fbx03
BR112015011798A2 (pt) métodos e composições para tratar doenças neurodegenerativas
ECSP14027694A (es) Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]